Literature DB >> 12847

Experience with incompatible maternal donors for bone marrow transplantation.

S A Feig, P M Falk, R C Neerhout, R Sparkes, R P Gale, G Opelz, M J Cline, J Fahey, G Smith, G Sarna, M Territo, L Young, E A Langdon, F Fawzi.   

Abstract

Marrow transplantation in aplastic anemia and leukemia has generally been limited to siblings who have been histocompatible at both the serological (A and B) and lymphocyte determined (D or MLC) loci of the HLA system. We studied three male patients, two with aplastic anemia and one with acute myelogenous leukemia, who received transplants from their histoincompatible mothers. MLC studies between donors and recipients showed varying degrees of stimulation. Definite engraftment occurred in one patient and transient engraftment in another. Engraftment in the third patient could not be evaluated. In the patient with sustained engraftment, there was clinical evidence of severe graft versus host disease (GVHD) however, this was not substantiated by histologic findings. This preliminary study suggests that MLC incompatibility may be more of an indicator of the risk of GVHD than of bone marrow rejection. If more effective control of GVHD can be accomplished, marrow transplantation between MLC-reactive individuals may become feasible.

Entities:  

Mesh:

Year:  1977        PMID: 12847     DOI: 10.1007/BF00997032

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  13 in total

Review 1.  Bone-marrow transplantation (second of two parts).

Authors:  E D Thomas; R Storb; R A Clift; A Fefer; L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-24       Impact factor: 91.245

Review 2.  Bone-marrow transplantation (first of two parts).

Authors:  E Thomas; R Storb; R A Clift; A Fefer; F L Johnson; P E Neiman; K G Lerner; H Glucksberg; C D Buckner
Journal:  N Engl J Med       Date:  1975-04-17       Impact factor: 91.245

3.  Bone-marrow transplantation from an HL-A non-identical but mixed-lymphocyte-culture identical donor.

Authors: 
Journal:  Lancet       Date:  1973-05-26       Impact factor: 79.321

4.  Minnesota experience in bone-marrow transplantation in man, 1968 to June 1973.

Authors:  B H Park; W D Biggar; R A Good
Journal:  Transplant Proc       Date:  1974-12       Impact factor: 1.066

Review 5.  A compendium of reported human bone marrow transplants.

Authors:  M M Bortin
Journal:  Transplantation       Date:  1970-06       Impact factor: 4.939

6.  Serotyping for homotransplantation. 18. Refinement of microdroplet lymphocyte cytotoxicity test.

Authors:  K K Mittal; M R Mickey; D P Singal; P I Terasaki
Journal:  Transplantation       Date:  1968-11       Impact factor: 4.939

7.  A semimicro mixed leukocyte culture test.

Authors:  D P Sengar; P I Terasaki
Journal:  Transplantation       Date:  1971-03       Impact factor: 4.939

8.  Allogeneic marrow grafting for treatment of aplastic anemia.

Authors:  R Storb; E D Thomas; C D Buckner; R A Clift; F L Johnson; A Fefer; H Glucksberg; E R Giblett; K G Lerner; P Neiman
Journal:  Blood       Date:  1974-02       Impact factor: 22.113

9.  Bone marrow transplantation between mixed lymphocyte culture-reactive individuals.

Authors:  R P Gale; G Opelz; R Sparkes
Journal:  Transplantation       Date:  1975-09       Impact factor: 4.939

10.  Allogeneic bone marrow transplantation in a patient with aplastic anemia using a phenotypically HL-A-identifcal unrelated donor.

Authors:  B Speck; F E Zwaan; J J van Rood; J G Eernisse
Journal:  Transplantation       Date:  1973-07       Impact factor: 4.939

View more
  2 in total

1.  Treatment of severe combined immunodeficiency by transplantation.

Authors:  D Niethammer
Journal:  Blut       Date:  1981-03

2.  Effect of colchicine on polymorphonuclear leucocyte chemotaxis in human volunteers.

Authors:  M Ehrenfeld; M Levy; M Bar Eli; R Gallily; M Eliakim
Journal:  Br J Clin Pharmacol       Date:  1980-09       Impact factor: 4.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.